ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM)

CUSIP: G6333L101

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Stock
Total 13F shares
5,076,439
Share change
-1,469,285
Total reported value
$1,800,325
Price per share
$0.36
Number of holders
26
Value change
-$575,766
Number of buys
7
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP G6333L101?
CUSIP G6333L101 identifies ITRM - ITERUM THERAPEUTICS PLC SHS NEW - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM) as of Q1 2022

As of 31 Mar 2022, ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM) was held by 26 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,076,439 shares. The largest 10 holders included Canaan Partners X LLC, New Leaf Venture Partners, L.L.C., FRANKLIN RESOURCES INC, Virtu Financial LLC, MORGAN STANLEY, GRIMES & COMPANY, INC., Verition Fund Management LLC, RENAISSANCE TECHNOLOGIES LLC, EDMOND DE ROTHSCHILD HOLDING S.A., and Focused Wealth Management, Inc. This page lists 26 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.